Gene expression product BLSJ-2 capable of diagnosing and identifying brucella and preparation method of gene expression product BLSJ-2

A BLSJ-2, Brucella technology, applied in biochemical equipment and methods, biological material analysis, enzymes, etc., can solve the problem of inability to distinguish Brucella vaccine immune antibodies

Pending Publication Date: 2017-05-31
CHINA INST OF VETERINARY DRUG CONTROL
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The purpose of the present invention is to solve the difficult problem that existing serological methods cannot distinguish Brucella vaccine immune antibodies and natural infection antibodies, pro

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gene expression product BLSJ-2 capable of diagnosing and identifying brucella and preparation method of gene expression product BLSJ-2
  • Gene expression product BLSJ-2 capable of diagnosing and identifying brucella and preparation method of gene expression product BLSJ-2
  • Gene expression product BLSJ-2 capable of diagnosing and identifying brucella and preparation method of gene expression product BLSJ-2

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] ——Screening research of differential diagnosis antigen protein spots

[0048] Differential diagnostic antigens were screened from membrane proteins of S2 strain by immunoproteomics method. Each of 30 brucellosis-negative healthy sheep, 30 S2 immunized sheep, and 30 clinical brucellosis-infected sheep-positive mixed sera were used for western-blotting (Western-blotting) with S2 strain membrane protein two-dimensional electrophoresis gel (2D), respectively. Looking for the difference between the S2 membrane protein and the serum reaction of sheep with different brucellosis status (infected / immune / negative), a total of 113 differential protein spots were found. A total of 30 protein spots with large differences in immune response were selected for matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometry identification and bioinformatics analysis. A total of 14 proteins were identified. These proteins undertake 13 types of molecular functions...

Embodiment 2

[0074] ——Determination of gene information of differential diagnosis antigen protein spot

[0075] The candidate protein spots obtained by the two methods were compared with the expressed proteins in the S2 genome information published on the website of the National Center for Biotechnology Information (NCBI), and the corresponding gene information of each candidate protein spot was obtained in Table 3 (including gene name information, Gene number, gene length, protein molecular weight, etc.), then respectively design primers and use PCR for gene cloning to obtain prokaryotic expression products (Table 3, image 3 , Figure 4 ), respectively with Brucella immune serum and Brucella natural infection serum by Western-blot (Western-blot) and indirect enzyme-linked immunosorbent assay (ELISA) to verify its differential diagnosis value ( Figure 5 ,Table 4).

[0076] 1. Eight candidate differential diagnosis antigens (Table 3), numbered #1-#8 respectively, and protein numbers are u...

Embodiment 3

[0092] ——Verification of differential diagnosis of 3# (glycoside hydrolase family 43, glycoside hydrolase family 43)

[0093] 1. Utilize glutathione S-transferase (GST) affinity chromatography column and glutathione gradient elution method to purify recombinant protein 8#, obtain the purified target protein of purity more than 90% ( Image 6 ).

[0094] 2. The results of the purified 3# recombinant protein brucellosis antibody enzyme-linked immunosorbent assay (ELISA)

[0095] Purified 3# recombinant protein under conventional conditions: choose 3 single parts of negative / immune / infected sera and 1 part of mixed negative / immune / infected sera, respectively use carbonate buffer solution of pH 9.6 to purify the recombinant protein The protein antigen was diluted to 100ng / mL, coated overnight at 4°C, blocked with 10% skimmed milk for 2 hours as a blocking solution, diluted 1:50 with PBS, and 1:50 for the enzyme-labeled secondary antibody with phosphate buffered saline (PBS). 500...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a gene expression product BLSJ-2 capable of diagnosing and identifying brucella and a preparation method of the gene expression product BLSJ-2. The product is obtained through prokaryotic expression of the gene with the genetic ID (GI) being 490823642 of the brucella S2 strain, and through purification adopting a glutathione S-transferase (GST) affinity chromatography column and glutathione gradient elution. The product is taken as a coating antigen, and can be used as a sera detection diagnosis antigen for distinguishing the animal Brucella vaccine immunity and natural infection. The antigen is subjected to western blot with the vaccine immunity antibody and the natural infection antibody, and the differences are obvious. The antigen is taken as the coating antigen for the enzyme-linked immunosorbent assay (ELASA), and is used for detecting hundreds of clinical serum samples of brucellosis, and the identification and diagnosis effects are obvious.

Description

[0001] Technical Field The present invention relates to a gene expression product BLSJ-2 with the function of diagnostic marker for Brucella and its preparation method, belonging to the field of veterinary microbiology diagnosis. Background technique [0002] Brucellosis (abbreviated as brucellosis) is a zoonotic infectious disease caused by Brucella. Human infection with brucellosis mainly comes from sick animals and their products. The source of infection related to human brucellosis in my country is mainly sick sheep and cattle, but Brucella melis is the most serious (Zhu Liangquan et al. Microbiology Bulletin, 2015(01): 171~177; Wu Qingmin. Veterinary Director Journal, 2011(09):46~47). [0003] Serological methods are currently the main method for diagnosing animal brucellosis, and vaccination is an important means of preventing animal brucellosis. The existing serological diagnosis of brucellosis is mainly based on the detection of anti-brucella lipopolysaccharide antibo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N9/24G01N33/573G01N33/569
CPCC12N9/2402G01N33/56911G01N33/573G01N2333/924
Inventor 朱良全张磊王团结丁家波冯宇张阁彭永高强
Owner CHINA INST OF VETERINARY DRUG CONTROL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap